JP2017502253A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502253A5
JP2017502253A5 JP2016521777A JP2016521777A JP2017502253A5 JP 2017502253 A5 JP2017502253 A5 JP 2017502253A5 JP 2016521777 A JP2016521777 A JP 2016521777A JP 2016521777 A JP2016521777 A JP 2016521777A JP 2017502253 A5 JP2017502253 A5 JP 2017502253A5
Authority
JP
Japan
Prior art keywords
antibody
ibs
vinculin
cdt
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016521777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017502253A (ja
JP6567509B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059957 external-priority patent/WO2015054529A1/en
Publication of JP2017502253A publication Critical patent/JP2017502253A/ja
Publication of JP2017502253A5 publication Critical patent/JP2017502253A5/ja
Application granted granted Critical
Publication of JP6567509B2 publication Critical patent/JP6567509B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016521777A 2013-10-09 2014-10-09 過敏性腸症候および炎症性腸疾患の診断および治療 Active JP6567509B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361888658P 2013-10-09 2013-10-09
US61/888,658 2013-10-09
PCT/US2014/059957 WO2015054529A1 (en) 2013-10-09 2014-10-09 Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease

Publications (3)

Publication Number Publication Date
JP2017502253A JP2017502253A (ja) 2017-01-19
JP2017502253A5 true JP2017502253A5 (enExample) 2017-11-16
JP6567509B2 JP6567509B2 (ja) 2019-08-28

Family

ID=52813648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016521777A Active JP6567509B2 (ja) 2013-10-09 2014-10-09 過敏性腸症候および炎症性腸疾患の診断および治療

Country Status (19)

Country Link
US (2) US9851361B2 (enExample)
EP (1) EP3054977B1 (enExample)
JP (1) JP6567509B2 (enExample)
KR (1) KR102259588B1 (enExample)
CN (1) CN105744956B (enExample)
AU (2) AU2014331841B2 (enExample)
BR (1) BR112016007474A2 (enExample)
CA (1) CA2923651C (enExample)
CL (1) CL2016000820A1 (enExample)
ES (1) ES2892905T3 (enExample)
IL (1) IL244971B2 (enExample)
MX (1) MX383423B (enExample)
NZ (1) NZ717633A (enExample)
PE (1) PE20160882A1 (enExample)
PL (1) PL3054977T3 (enExample)
PT (1) PT3054977T (enExample)
RU (1) RU2683781C2 (enExample)
SG (1) SG11201601733VA (enExample)
WO (1) WO2015054529A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11693009B2 (en) 2009-02-11 2023-07-04 Cedars-Sinai Medical Center Methods for detecting post-infectious irritable bowel syndrome
CA2752033C (en) 2009-02-11 2020-03-24 Cedars-Sinai Medical Center Antibody to cytolethal distending toxin of campylobacter jejuni
ES2646598T3 (es) 2012-09-17 2017-12-14 Cedars-Sinai Medical Center Diagnóstico y tratamiento de los trastornos de la motilidad del intestino y la vejiga, y de la fibromialgia
AU2014331841B2 (en) 2013-10-09 2020-03-12 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
MX384921B (es) 2014-10-09 2025-03-14 Cedars Sinai Medical Center Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca.
CN106053827A (zh) * 2016-05-17 2016-10-26 上海凯璟生物科技有限公司 一种肠易激综合症标志物Vinculin抗体检测试剂盒及其制备方法
CN105784989A (zh) * 2016-05-17 2016-07-20 上海凯璟生物科技有限公司 一种肠易激综合症标志物CdtB抗体检测试剂盒及其制备方法
WO2017201461A1 (en) 2016-05-20 2017-11-23 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease based on genes
JP2020507755A (ja) 2017-01-30 2020-03-12 シーダーズ−サイナイ メディカル センター 強皮症の診断法
RU2763258C1 (ru) * 2020-07-13 2021-12-28 Евгения Николаевна Воронина Способ дифференциальной диагностики воспалительных заболеваний кишечника у детей по комплексу клинико-анамнестических, лабораторных и инструментальных критериев

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691151A (en) * 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
FR2806805A1 (fr) 2000-03-22 2001-09-28 Centre Nat Rech Scient SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS
WO2003097854A2 (en) * 2002-05-17 2003-11-27 Sugen, Inc. Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
JP2006515165A (ja) 2002-09-16 2006-05-25 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法
US7595386B2 (en) 2003-01-24 2009-09-29 William Beaumont Hospital Methods and compositions for heat activated gene therapy using cytolethal distending toxin
BRPI0409128A (pt) * 2003-04-08 2006-03-28 Progenics Pharm Inc uso de antagonistas de opióides periféricos, especialmente metilnaltrexona para tratar sìndrome de intestino irritável
EP1664796B1 (en) * 2003-09-15 2010-12-15 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate ankylosing spondylitis
KR101152078B1 (ko) 2003-12-05 2012-06-21 후소 야쿠힝 고교 가부시끼가이샤 세포팽창화 치사독 및 그것을 표적으로 한 캄필로박터속에속하는 세균의 검출
EP2102367A2 (en) 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
DK2223121T3 (da) 2007-12-20 2012-10-22 Index Diagnostics Ab Publ Fremgangsmåde og kit til anvendelse ved differentiering mellem ibd og ibs og yderligere skelnen mellem ibd-sygdomstyper
ES2529060T3 (es) 2008-11-24 2015-02-16 Cedars-Sinai Medical Center Derivados antioxidantes de la camptotecina y nanoesferas antineoplásicas antioxidantes de los mismos
MX2011008354A (es) 2009-02-11 2011-09-06 Cedars Sinai Medical Center Terapia antibiotica para reducir la probabilidad de desarrollar el sindrome del intestino irritable post-infeccioso.
CA2752033C (en) 2009-02-11 2020-03-24 Cedars-Sinai Medical Center Antibody to cytolethal distending toxin of campylobacter jejuni
FR2942541A1 (fr) 2009-02-25 2010-08-27 Assist Publ Hopitaux De Paris Procede de diagnostic d'une vascularite
RU2397178C1 (ru) * 2009-02-27 2010-08-20 Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса
IT1400989B1 (it) 2010-07-13 2013-07-05 Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale.
GB201017520D0 (en) 2010-10-15 2010-12-01 Sense Proteomic Ltd Biomarkers
ES2646598T3 (es) 2012-09-17 2017-12-14 Cedars-Sinai Medical Center Diagnóstico y tratamiento de los trastornos de la motilidad del intestino y la vejiga, y de la fibromialgia
AU2014331841B2 (en) 2013-10-09 2020-03-12 Cedars-Sinai Medical Center Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
MX384921B (es) 2014-10-09 2025-03-14 Cedars Sinai Medical Center Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca.
CN106091069A (zh) 2016-06-15 2016-11-09 安徽省绿巨人环境技术有限公司 一种废水再利用装置
JP2020507755A (ja) 2017-01-30 2020-03-12 シーダーズ−サイナイ メディカル センター 強皮症の診断法

Similar Documents

Publication Publication Date Title
JP2017502253A5 (enExample)
JP7022969B2 (ja) SARS-CoV-2感染症を診断するための方法および試薬
Lee Procalcitonin as a biomarker of infectious diseases
JP2010514805A5 (enExample)
RU2016116766A (ru) Диагностика и лечение синдрома раздраженного кишечника и воспалительного заболевания кишечника
JP2011516038A5 (enExample)
US10114028B2 (en) Biomarkers for pneumonia and acute decompensated heart failure
JP2017524130A5 (enExample)
CN102395887A (zh) 用于检测降钙素原的免疫测定法
US11598772B2 (en) Method and products for the diagnosis of a seafood allergy
EP3320341A1 (en) Prognosis and monitoring of membranous nephropathy based on the analysis of pla2r1 epitope profile and spreading
JP2017531801A5 (enExample)
RU2017115663A (ru) Способы и системы для отличия синдрома раздраженного кишечника от воспалительного заболевания кишечника и глютеновой болезни
JP2018515071A5 (enExample)
TW201231670A (en) A kit for examining plasma or serum antibody titers against periodontal pathogens
JP6609570B2 (ja) がんを検出するための方法およびバイオマーカー
ES2793001T3 (es) Marcadores diagnósticos de inmunosenescencia y métodos para determinar la susceptibilidad a las infecciones nosocomiales
US9068993B2 (en) Diagnostic assays and methods of use for detection of filarial infection
WO2020190700A1 (en) Autoantibodies as biomarker of paraneoplastic encephalitis associated with testicular cancer
CN113366012A (zh) 幽门螺杆菌菌株的鉴定方法及鉴定试剂盒
KR102128251B1 (ko) 아르기닌이 메틸화된 drd2에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
JPWO2011138955A1 (ja) Siaα2−8Siaα2−3Galβ−R糖鎖を持つムチン1の分析方法
WO2019135477A3 (ko) 다복제유전자를 이용한 쯔쯔가무시병의 진단방법
JP6325177B2 (ja) 腎癌薬物療法の効果判定のための血中バイオマーカー
WO2016063253A1 (en) A method and a kit to predict prognosis in patients with relapsing remitting multiple sclerosis and poor prognosis: a decision making tool for prescription of treatment